---
title: "This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289910759.md"
description: "Raymond James analyst Christopher Raymond initiated coverage on Aktis Oncology Inc (NASDAQ:AKTS) with a Strong Buy rating and set a price target of $40. This follows the stock's Monday close at $20.69. Other initiations included BNP Paribas' Underperform on PDD Holdings, HC Wainwright's Buy on Brazil Potash, and BTIG's Buy on Better Home & Finance."
datetime: "2026-06-16T11:15:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289910759.md)
  - [en](https://longbridge.com/en/news/289910759.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289910759.md)
---

# This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   BNP Paribas analyst Colin Liu initiated coverage on **PDD Holdings Inc – ADR** (NASDAQ:PDD) with an Underperform rating and announced a price target of $89. PDD Holdings shares closed at $83.55 on Monday. See how other analysts view this stock.
-   Raymond James analyst Christopher Raymond initiated coverage on **Aktis Oncology Inc** (NASDAQ:AKTS) with a Strong Buy rating and announced a price target of $40. Aktis Oncology shares closed at $20.69 on Monday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Heiko F. Ihle initiated coverage on **Brazil Potash Corp** (AMEX:GRO) with a Buy rating and announced a price target of $4.75. Brazil Potash shares closed at $2.19 on Monday. See how other analysts view this stock.
-   BTIG analyst Douglas Harter initiated coverage on **Better Home & Finance Holding Co** (NASDAQ:BETR) with a Buy rating and announced a price target of $36. Better Home & Finance shares closed at $28.83 on Monday. See how other analysts view this stock.

Considering buying AKTS stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [AKTS.US](https://longbridge.com/en/quote/AKTS.US.md)
- [GRO.US](https://longbridge.com/en/quote/GRO.US.md)
- [PDD.US](https://longbridge.com/en/quote/PDD.US.md)
- [BETR.US](https://longbridge.com/en/quote/BETR.US.md)
- [BETRW.US](https://longbridge.com/en/quote/BETRW.US.md)
- [PDDL.US](https://longbridge.com/en/quote/PDDL.US.md)
- [KPDD.US](https://longbridge.com/en/quote/KPDD.US.md)
- [BNPQY.US](https://longbridge.com/en/quote/BNPQY.US.md)
- [RJF.US](https://longbridge.com/en/quote/RJF.US.md)
- [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md)

## Related News & Research

- [Aktis Oncology (NASDAQ:AKTS) Posts Earnings Results, Meets Expectations](https://longbridge.com/en/news/295844401.md)
- [Shein's slowing growth tests investor appetite ahead of Hong Kong IPO](https://longbridge.com/en/news/295680641.md)
- [BTIG Keeps Their Buy Rating on Better Home & Finance (BETR)](https://longbridge.com/en/news/295965330.md)
- [Brazil Potash posts investor deck outlining Autazes potash project economics and financing plan](https://longbridge.com/en/news/296137457.md)
- [04:30 ETTemu partners with Danish Startup Group to support the Danish startup ecosystem](https://longbridge.com/en/news/296196684.md)